Skip to content
Disclosery

13F-HR filed by RP Management, LLC

RP Management, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 3 holding rows worth $84,917,966.

Accession
0001507673-23-000004
Filer
CIK 1507673
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 3 entries on the cover page, a total value of $84,917,966 stated on the cover page (in dollars after the unit check, H1), rows summing to $84,917,966 with VALUE read as dollars as filed, 13F file number 028-19261. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock3,846,154$44,153,847dollars as filed
BIOHAVEN LTDG1110E107COM2,936,507$40,758,717dollars as filed
VIRACTA THERAPEUTICS INC92765F108COM3,700$5,402dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001507673-23-000004this filing2023-02-14acceptance time not in the bulk data set